Center for Opioid Epidemiology & Policy News | NYU Langone Health

Skip to Main Content
Center for Opioid Epidemiology & Policy Center for Opioid Epidemiology & Policy News

Center for Opioid Epidemiology & Policy News

Stay up to date on COVID-19 related guidance and resources relevant to medications for opioid use disorder and opioid treatment programs, and explore recent developments in opioid epidemiology and policy. Please join our mailing list.

COVID-19 Resources Related to Opioid Epidemiology and Policy

Following the development of the COVID-19 pandemic, various organizations and government agencies have issued guidance documents and resources relevant to substance use disorder treatment and medication. NYU Langone’s Center for Opioid Epidemiology and Policy has compiled a list of these prescribing updates, guidance, and resources for patients and providers relevant to medications for opioid use disorder and opioid treatment programs.

News

Potential Implications of COVID-19 for People With Substance Use Disorders

Read More
Read more: Potential Implications of COVID-19 for People With Substance Use Disorders

SAMHSA Resources and Information

The Substance Abuse and Mental Health Services Administration (SAMHSA) has created a list of resources and guidance to aid individuals, providers, communities, and states during the COVID-19 pandemic. Visit their resource page.

DEA COVID-19 Resources

The U.S. Drug Enforcement Administration (DEA) has provided resources on medication and treatment for substance use disorders in the context of COVID-19. Visit their resource page.

ASAM COVID-19 Resources

The American Society of Addiction Medicine (ASAM)’s Caring for Patients During COVID-19 (CPDC) Task Force has produced a resource list pertaining to tailored addiction medicine treatment. Visit their resource page.

NIDA COVID-19 Resources

The National Institute on Drug Abuse (NIDA) has compiled a list of resources for people with substance use disorder and who are in recovery to help cope with the unique challenges presented by COVID-19. Visit their resource page.

Vital Strategies Resources for Drug Use and COVID-19 Risk Reduction

Vital Strategies, Inc., has created a resource list for people who use drugs and stakeholders likely to engage with people who use drugs. Visit their resource page.

Recent Opioid Epidemiology and Policy Developments

Stay up to date with recent news in opioid epidemiology and policy.

Linked Statewide Data Used for Predictive Risk Modeling of Opioid Overdoses

Noa Krawczyk, PhD, and a team of investigators found that the risk of fatal and nonfatal opioid overdose could be accurately predicted using linked Maryland hospital and criminal justice data. Read the full article.

New England Journal of Medicine Podcast Examines the Association Between Legalized Marijuana and Traffic Fatalities

Magdalena Cerdá, DrPH, MPH, director of NYU Langone’s Center for Opioid Epidemiology and Policy, and Dr. Julian Santaella-Tenorio joined Joe Elia and Dr. Ali Raja on Journal Watch, a New England Journal of Medicine podcast, to discuss the impact of legalized recreational cannabis on traffic fatalities in Colorado and Washington State. Listen to the Journal Watch podcast.

Medication Treatment for Opioid Use Disorder Decreases Risk of Fatal Overdose

Research led by Dr. Krawczyk, found that medication treatment for opioid use disorder in Maryland was associated with longer treatment retention and an 80 percent lower risk of fatal overdose. Read the full article.

Medicaid Expansion Associated with Fewer Total Opioid Overdose Deaths

A team of investigators, including Dr. Cerdá, found that Medicaid expansion under the Affordable Care Act was associated with reductions in total opioid overdose deaths. Read the full article.

Researchers Advocate for Improved Data Sharing at Opioid Task Force Meeting

Dr. Cerdá testified in front of the New York State Joint Senate Task Force on Opioids, Addiction, and Overdose Prevention to advocate for policies that expand data linkage and sharing across health, social service, and criminal justice agencies. Watch the full public hearing.

Epidemiology Counts Podcast Examines the Origins of the Opioid Epidemic

Dr. Cerdá and Dr. Krawczyk joined Matt Fox on the official podcast for the Society for Epidemiological Research to answer fundamental questions about what caused the opioid epidemic, how it has evolved over time, and what we can do to address this public health crisis. Listen to the Epidemiology Counts podcast.

Substance Use Panel Highlights Opioid Interventions and Policy Implications

Dr. Cerdá spoke on a panel hosted by the Association of Foreign Correspondents in the United States (AFC-USA). The panel brought together several substance abuse disorder experts to discuss the current opioid crisis in the US, emerging interventions, and necessary policy actions to accelerate prevention and cross-sector engagement. Watch the full panel discussion.

Physician-Targeted Marketing Linked to Opioid Overdose Deaths

Research by Dr. Cerdá and her team of investigators found that increased marketing of opioid products to physicians was associated with higher opioid prescribing rates and opioid deaths in the United States. Read the full article.

A New Machine-Learning Tool Will Predict High-Risk Neighborhoods

A new machine-learning forecasting model, Preventing Overdose Using Information and Data from the Environment (PROVIDENT), seeks to predict which neighborhoods in Rhode Island are at highest risk for outbreaks of opioid overdose. With Dr. Cerdá as co-principal investigator, the project will unite faculty from NYU Langone’s Center of Opioid Epidemiology and Policy with colleagues from Brown University’s School of Public Health. Read the full article.

News

Marijuana Legalization May Lead to More Problematic Use Among Adults

Read More
Read more: Marijuana Legalization May Lead to More Problematic Use Among Adults
News

Despite Cost-Effectiveness of Naloxone, Barriers to Access Persist

Read More
Read more: Despite Cost-Effectiveness of Naloxone, Barriers to Access Persist